Huabing Li

33PUBLICATIONS
104CO-AUTHORS
Haematological tumoursMedical infection agents (incl. prions)Nanotoxicology, health and safetyGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Aug 25, 2026
Inhibition of nucleoporin 214 depletes leukemia stem cells by promoting heme catabolism and lipid peroxidation.

|Aug 19, 2026
Blocking the m6Am methyltransferase PCIF1 in macrophages attenuates colitis progression by preventing neuronal damage.

|Jul 27, 2026
Blocking the m6Am methyltransferase PCIF1 releases STAT1-mediated Th1 immunity to potentiate cancer immunotherapy.

|May 29, 2026
RNA Helicase DDX21 Controls CD4+ T Cell Proliferation and Promotes Inflammatory Bowel Disease via Translational Control.

|May 13, 2026
m6A RNA modification guides alternative polyadenylation to maintain T cell quiescence.

|Jan 14, 2026
tRNA m1A modification orchestrates STING translation in macrophages to enhance antitumor immunity and CAR-macrophage immunotherapy.

Xuefei Wang, Xudong Wang, Hao Li

Pageof 6

Frequent Collaborators

14 joint publications

Richard A Flavell

11 joint publications

Youqiong Ye

6 joint publications

Bing Su

6 joint publications

Bin Li